Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Insider sale notice for Enovix Corp (ENVX). The filing reports that 120,000 common shares, originally issued as restricted stock units on
Insider share withholding and holdings update at Enovix (ENVX). An officer, Kristina Truong, had 637 shares of common stock withheld on
Ajay Marathe, Chief Operating Officer of Enovix Corporation (ENVX), reported the sale of 120,000 shares of common stock on
Enovix Corp insider Arthi Chakravarthy, the company's Chief Legal Officer, reported a transaction on 10/01/2025 tied to the vesting of restricted stock units. A total of 3,331 shares of Enovix common stock were surrendered to satisfy tax withholding at an effective price of $11.11 per share. After that withholding, the reporting person is shown as beneficially owning 431,472 shares in total.
The reported beneficial ownership includes 321,539 shares that remain issuable upon settlement of outstanding RSUs, indicating a sizeable portion of the holding is tied to unvested equity awards rather than fully issued shares.
Ajay Marathe, listed as Chief Operating Officer and a director of Enovix Corp (ENVX), reported a transaction dated 10/01/2025. The filing shows the withholding of 4,440 shares of common stock at a price of $11.11 to satisfy tax withholding related to the vesting of restricted stock units (RSUs), where each RSU converts into one share upon settlement. After this withholding, the reporting person beneficially owns 1,147,259 shares in total; that total includes 785,681 shares that remain issuable upon settlement of outstanding RSUs. The Form 4 was signed by an attorney-in-fact on 10/03/2025. No derivative transactions are reported on this Form 4.
Raj Talluri, President and CEO of Enovix Corp (ENVX), reported a transaction on 10/01/2025 in which 15,539 shares of common stock were disposed to satisfy tax withholding related to the vesting of restricted stock units (RSUs) at a price of $11.11 per share. After this withholding, the filing shows the Reporting Person beneficially owns 2,352,762 shares, which includes 1,782,997 shares issuable upon settlement of outstanding RSUs. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Enovix (ENVX) filed a Form 4 disclosing an insider tax-withholding transaction. On 10/01/2025, the Chief Accounting Officer reported a code F event tied to RSU vesting, with 2,221 shares withheld at $11.11 to cover taxes.
Following the transaction, direct beneficial ownership was 201,312 shares. The filing notes 164,632 additional shares are issuable upon settlement of previously granted RSUs. Each RSU represents one share of common stock.
Enovix Corp (ENVX) insider transaction: Chief Legal Officer Arthi Chakravarthy reported a disposition of 2,217 shares of Enovix common stock on 09/24/2025 at a price of $10.31 per share. The filing states the sale reflects shares withheld to satisfy tax withholding obligations upon RSU vesting rather than an open-market sale. After the transaction, Chakravarthy beneficially owned 434,803 shares, which includes 327,840 shares issuable upon settlement of RSUs. The Form 4 is signed 09/26/2025 and contains no other transactions or derivative activity.
Talluri Rajendra K, President and CEO and director of Enovix Corporation (ENVX), reported a transaction on 09/18/2025 showing 17,617 shares of common stock disposed of at a price of $9.96. The filing explains these shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 2,368,301 shares, which includes 1,812,399 shares issuable upon settlement of outstanding RSUs. The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Insider transfer and holdings update: Thurman J. Rodgers, a director and greater-than-10% owner of Enovix Corporation, reported transactions on 09/18/2025. He transferred 5,635 shares to the Rodgers Massey Revocable Living Trust dated 4/4/11, of which he is trustee and retains voting and dispositive power. On the same date, 5,635 shares were acquired (reported as an acquisition at $0). Following these transactions, Rodgers directly holds 16,908 shares reported as issuable upon settlement of restricted stock units (RSUs) and indirectly holds additional shares through trust accounts, including 1,120,114 shares held in a trust and other trust-held shares, with total indirect beneficial ownership noted as 20,864,042 shares.